Pharmacyclics Inc. (PCYC) Stock Quote

Detailed Quote for Pharmacyclics Inc. (PCYC)

After Hours: $ 23.29

0.06 (+0.26%)

Volume: 3.9 k

7:40 PM EST Feb 10, 2012

close 52 Week Information

52 Week High

February 10, 2012

Close: 23.57

52 Week Low

March 2, 2011

Close: 4.75

Today

Last Price
23.23

Change $
3.432

Change %
17.34%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
19.60

High
23.57

Low
19.3901

Prev Close
19.798

Last Trade
4:00

Volume
3.94 m

52 Wk Hi
23.57

52 Wk Low
4.75

Market Cap
1.6 b

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
68,700,360

EPS (TTM)
-0.67

PE Ratio
N/A

close Exchange Information Listed On Nasdaq Small Caps (NSC) Exchange
NSC

News and Media for Pharmacyclics Inc. (PCYC)

Sector News | Topic News

News for PCYC

Thu, Feb 09, 2012

6:30 AM

Pharmacyclics Reports Fiscal 2012 Second Quarter Financial Results - PR Newswire

Mon, Dec 19, 2011

7:00 AM

Pharmacyclics Inc. Receives Issue Notice of Significant Bruton's Tyrosine Kinase (BTK) Patent - PR Newswire

Tue, Dec 13, 2011

11:30 AM

Pharmacyclics® Announces Updated Results for BTK Inhibitor PCI-32765 for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma at American Society for Hematology (ASH) Annual Meeting - PR Newswire

Mon, Dec 12, 2011

2:15 PM

Pharmacyclics® Reports Interim Phase II Trial Results for BTK Inhibitor PCI-32765 in Mantle Cell Lymphoma at American Society of Hematology (ASH) Annual Meeting - PR Newswire

Thu, Dec 08, 2011

4:21 PM

Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765 - PR Newswire

4:07 PM

Pharmacyclics Forms Pact to Develop and Commercialize PCI-32765 for Hematologic Cancers with Janssen Biotech, Inc. - PR Newswire

Fri, Dec 02, 2011

6:00 AM

Pharmacyclics Appoints Chief Medical Officer Dr. Lori Anne Kunkel - PR Newswire

Mon, Nov 07, 2011

7:00 AM

Pharmacyclics Reports Fiscal 2012 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 53rd American Society of Hematology Annual Meeting - PR Newswire

Mon, Sep 12, 2011

4:11 PM

Pharmacyclics Reports Financial Results and Recent Developments for Fiscal Year and Fourth Quarter 2011 - Conference Call Set for Today at 4:30 PM EDT - PR Newswire

Thu, Sep 08, 2011

4:00 PM

Pharmacyclics Announces Date of Fiscal Year End 2011 Financial Results and Conference Call - PR Newswire

Thu, Aug 25, 2011

11:47 AM

Thursday's Movers in Healthcare include Cutera, Vanda Pharmaceuticals and Sanuwave - Accesswire

More News for PCYC >>

Tags for Pharmacyclics Inc.

Research stocks or mutual funds related to Pharmacyclics Inc. by keywords or tags. Find companies that have a similar focus to PCYC. The keywords below have been associated to PCYC by either user submission or electronic means.

stock forecasting stock trading clinical trial enrollment king report on corporate governance clinical research software stock investments online presentations hot stock picks stock information forecasting stock prices annual report stock market ticker stock investment trail clinical japan stock quotes drug design stock markets stock market chart stock quote robert stock annual report photography corporate governance practices stock alerts phase iii clinical trials report on corporate governance corporate governance issues shareholder clinical research factor viia stock symbols annual report printing define corporate governance xom stock quote board of directors role stock market quotes company annual reports cdk inhibitors phase 3 clinical trials credit annual report clinical trials manager stock price forecasting receptor tyrosine kinase corporate governance disclosure creating presentations board of directors governance histone deacetylase stock news stock trades directors duties board governance